8th April 2020:  NICE has developed a medtech innovation briefing (MIB) on Lifelight First for monitoring vital signs

NICE MEDTECH INNOVATION BRIEFING SUMMARY:

  • “The technology described in this briefing is Lifelight First. It is used for measuring indicative estimates of blood pressure (mmHg), pulse rate (beats per minute), and respiration rate (respirations per minute) in people who need vital sign measurements.
  • The innovative aspects are that it does not make direct contact with people or medical hardware, potentially limiting cross-contamination. It also uses algorithms to analyse the measurements.
  • The intended place in therapy would be hospitals, clinics and other healthcare settings and for people that need vital sign monitoring. It may be particularly useful when current methods cannot readily be used.”

Source: Click here to read NICE’s Medtech innovation briefing (MIB)

8th April 2020:  NICE has developed a medtech innovation briefing (MIB) on Lifelight First for monitoring vital signs

NICE MEDTECH INNOVATION BRIEFING SUMMARY:

  • “The technology described in this briefing is Lifelight First. It is used for measuring indicative estimates of blood pressure (mmHg), pulse rate (beats per minute), and respiration rate (respirations per minute) in people who need vital sign measurements.
  • The innovative aspects are that it does not make direct contact with people or medical hardware, potentially limiting cross-contamination. It also uses algorithms to analyse the measurements.
  • The intended place in therapy would be hospitals, clinics and other healthcare settings and for people that need vital sign monitoring. It may be particularly useful when current methods cannot readily be used.”

Source: Click here to read NICE’s Medtech innovation briefing (MIB)

8th April 2020:  NICE has developed a medtech innovation briefing (MIB) on Lifelight First for monitoring vital signs

NICE MEDTECH INNOVATION BRIEFING SUMMARY:

  • “The technology described in this briefing is Lifelight First. It is used for measuring indicative estimates of blood pressure (mmHg), pulse rate (beats per minute), and respiration rate (respirations per minute) in people who need vital sign measurements.
  • The innovative aspects are that it does not make direct contact with people or medical hardware, potentially limiting cross-contamination. It also uses algorithms to analyse the measurements.
  • The intended place in therapy would be hospitals, clinics and other healthcare settings and for people that need vital sign monitoring. It may be particularly useful when current methods cannot readily be used.”

Source: Click here to read NICE’s Medtech innovation briefing (MIB)